Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
Nice International airport has from today Monday 26th October set up, on an experimental basis, the use of rapid antigenic tests for Covid-19 for cer...
Read More
France has reached a new record in the number of Covid-19 cases with 52,000 new cases recorded in the last 24 hours on Sunday. Over the last seven day...
Read More
The Alpes-Maritimes and the Var are amongst 54 departments in France to be subject to curfew restrictions from midnight tonight...
Read More
Curfew-Curfew restrictions come into force in the Alpes-Maritimes and Var from midnight tonight with members of the public required to stay at home fr...
Read More
